Movano (MOVE)
NASDAQ:MOVE
Top Page
Movano
(NASDAQ:MOVE)
Select Model
Select Model
Rating:52Neutral
Price Target:
$11.00
▲(57.59% Upside)
Action:ReiteratedDate:04/09/26
The score is held down primarily by very weak financial performance (minimal revenue scale, ongoing losses and cash burn, and negative equity). Technicals are a key offset with a strong multi-timeframe uptrend and neutral momentum readings. Valuation is unattractive/unclear due to negative earnings and no dividend, while recent corporate events are supportive (merger and Nasdaq compliance) but carry monitoring and structure-related risk.
Positive Factors
Strategic merger expands product mix
The Corvex merger brings a pure‑play AI cloud infrastructure business and complementary tech capabilities, diversifying the firm beyond medical wearables. This materially bolstered equity to satisfy Nasdaq and creates potential B2B revenue and product integration avenues over the medium term.
Negative Factors
Negative stockholders' equity
A swing to negative equity indicates capital erosion and a weakened asset base, limiting the company’s capacity to absorb future losses and constraining access to favorable financing. Negative equity is a structural credit and governance concern that impairs long‑term financial flexibility and investor confidence.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic merger expands product mix
The Corvex merger brings a pure‑play AI cloud infrastructure business and complementary tech capabilities, diversifying the firm beyond medical wearables. This materially bolstered equity to satisfy Nasdaq and creates potential B2B revenue and product integration avenues over the medium term.
Read all positive factors
Movano (MOVE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$18.14M
Dividend YieldN/A
Average Volume (3M)27.47K
Price to Earnings (P/E)―
Beta (1Y)1.13
Revenue Growth-44.57%
EPS Growth55.97%
CountryUS
Employees32
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,641,628
10 Day Avg. Volume32,926
30 Day Avg. Volume27,469
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)-2.01K
Price to Sales (P/S)16134.83
P/FCF Ratio-620.02
Enterprise Value/Market Cap0.31
Enterprise Value/Revenue12.83
Enterprise Value/Gross Profit-3.02
Enterprise Value/Ebitda-0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Movano Business Overview & Revenue Model
Company Description
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into ...
How the Company Makes Money
Movano’s monetization is intended to come primarily from (1) sales of its wearable devices (e.g., its smart ring) through direct-to-consumer and/or channel distribution, and (2) recurring software and services revenue tied to its digital platform,...
Movano Financial Statement Overview
Summary
Income Statement
10
Very Negative
Balance Sheet
28
Negative
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 433.00K | 1.01M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -1.84M | -1.99M | -158.00K | -134.00K | -74.00K |
| EBITDA | -15.17M | -24.06M | -29.13M | -30.20M | -20.82M |
| Net Income | -18.29M | -23.73M | -29.28M | -30.20M | -22.58M |
Balance Sheet | |||||
| Total Assets | 5.60M | 11.32M | 9.42M | 13.24M | 36.27M |
| Cash, Cash Equivalents and Short-Term Investments | 2.83M | 7.90M | 6.12M | 10.76M | 33.60M |
| Total Debt | 0.00 | 186.00K | 217.00K | 426.00K | 0.00 |
| Total Liabilities | 9.07M | 3.96M | 5.97M | 5.33M | 3.54M |
| Stockholders Equity | -3.47M | 7.36M | 3.45M | 7.92M | 32.73M |
Cash Flow | |||||
| Free Cash Flow | -11.27M | -22.54M | -26.24M | -25.01M | -16.75M |
| Operating Cash Flow | -11.27M | -22.53M | -26.18M | -24.90M | -16.18M |
| Investing Cash Flow | 0.00 | -8.00K | -64.00K | 15.72M | -16.70M |
| Financing Cash Flow | 6.19M | 24.32M | 21.60M | 2.26M | 44.85M |
Movano Technical Analysis
Positive
6.98
Price Trends
10.13
Positive
8.41
Positive
6.74
Positive
Market Momentum
0.15
Positive
53.44
Neutral
38.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOVE, the sentiment is Positive. The current price of 6.98 is below the 20-day moving average (MA) of 10.39, below the 50-day MA of 10.13, and above the 200-day MA of 6.74, indicating a bullish trend. The MACD of 0.15 indicates Positive momentum. The RSI at 53.44 is Neutral, neither overbought nor oversold. The STOCH value of 38.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MOVE.
Movano Risk Analysis
Movano disclosed 38 risk factors in its most recent earnings report. Movano reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 2 New Risks
1.
Our efforts may never demonstrate the feasibility of our proposed CGM and blood pressure monitoring solution. Q4, 2023
2.
Failure to comply with privacy and security laws and regulations could result in fines, penalties and damage to our reputation and have a material adverse effect on our business. Q4, 2023
Movano Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | $18.14M | -382.08 | -647.90% | ― | -44.57% | 55.97% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $1.99M | -0.18 | -145.52% | ― | ― | 97.70% | |
44 Neutral | $2.96M | -0.05 | -202.20% | ― | -49.63% | 82.22% | |
| ― | $4.53M | -0.38 | -228.82% | ― | ― | 63.87% |
* Healthcare Sector Average
MOVE
Movano
11.05
3.25
41.58%
BBLG
Bone Biologics
1.28
-2.73
-68.08%
BJDX
Bluejay Diagnostics
2.05
-7.87
-79.33%
TIVC
Tivic Health Systems
1.03
-3.79
-78.63%
AMIX
Autonomix Medical, Inc.
0.40
-1.23
-75.64%
Movano Corporate Events
Delistings and Listing ChangesRegulatory Filings and Compliance
Movano Regains Nasdaq Compliance, Enters One-Year Monitoring
Positive
Apr 9, 2026
On October 1, 2025, Corvex, Inc. was notified by Nasdaq that it was not in compliance with the exchange’s minimum stockholders’ equity requirement, but on December 18, 2025, the Nasdaq Hearings Panel granted the company an extension un...
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesDividendsM&A TransactionsRegulatory Filings and Compliance
Movano Completes Corvex Merger and Retains Nasdaq Listing
Positive
Mar 19, 2026
On March 19, 2026, Movano Inc. completed an all-stock merger with AI cloud computing specialist Corvex, Inc., with Corvex surviving as a wholly owned subsidiary and the combined company set to be renamed Corvex, Inc. effective March 23, 2026, whil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.